Skip to main content
. 2015 Oct 28;20:367–373. doi: 10.1007/s11605-015-2995-9

Table 2.

Adverse events

Patient Operation Response CTCAE grading Adverse event
1 2 × PIPAC, small bowel resection CR 1 Abdominal pain
2 1 × PIPAC N/A 1 CRP
3 4 × PIPAC CR 1 CRP
4 1× PIPAC, ileostomy N/A 3 CRP, Cholangitis
5 4 × PIPAC PR 3 Hepatotoxicity, abdominal pain
6 2× PIPAC SD 1 CRP
7 4× PIPAC PD 1 CRP
8 1× PIPAC N/A 1 Abdominal pain
9 5× PIPAC CR 1 Abdominal pain, CRP
10 5 × PIPAC, adhesiolysis, incisional hernia repair CR 1 Hepatotoxicity, CRP
11 4× PIPAC PR 4 Allergy, myolysis
12 3× PIPAC, small bowel resection PR 3 Hepatotoxicity, abdominal pain
13 3× PIPAC CR 1 Abdominal pain, CRP
14 1× PIPAC N/A 1 CRP
15 2× PIPAC PR 1 CRP
16 2× PIPAC PR 1 N/V, CRP
17 3× PIPAC SD 1 Renal toxicity, CRP
18 2× PIPAC, gastrectomy CR 1 CRP
19 2× PIPAC PR 5 CRP, Hepatotoxicity, progressive SBO, death
20 1× PIPAC N/A 3 CRP, Hepatotoxicity
21 2× PIPAC PD 3 Hepatotoxicity
22 1× PIPAC N/A 5 Ascites decompensation, death
23 5× PIPAC SD 3 Hepatotoxicity, CRP, 2 × Access lesion
24 1× PIPAC N/A 1 Access site extravasation

PIPAC pressurized intraperitoneal aerosol chemotherapy, CRS cytoreductive surgery, CTCAE Common Terminology Criteria for Adverse Events Version 4.0, CR complete remission, PR partial remission, SD stable disease, PD progressive disease, CRP C-reactive protein, RT renal toxicity, N/V nausea–vomiting, SBO small bowel obstruction